<DOC>
	<DOCNO>NCT00425919</DOCNO>
	<brief_summary>The purpose study learn whether PPM-204 effect lower blood glucose ( blood sugar ) level safe treat people type 2 diabetes .</brief_summary>
	<brief_title>Study Evaluating PPM-204 In Subjects With Type 2 Diabetes</brief_title>
	<detailed_description>The objective study identify dos PPM-204 therapeutically effective well tolerate improve glycemic control 24 week treatment subject type 2 diabetes mellitus ( T2DM ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men woman nonchildbearing potential , 18 70 year old Subjects currently treat diet exercise alone subject receive single oral antidiabetic medication BMI &gt; 23 &lt; 43 For subject currently treat 1 antidiabetic medication : HbA1c great equal 6.8 % less equal 8.5 % . For subject currently treat antidiabetic medication : HbA1c great equal 7.2 % less equal 9.0 % Subjects require insulin therapy Subjects currently receive 2 oral antidiabetic medication Subjects require systemic corticosteroid , unless treatment discontinue least 4 week screen visit Subjects receive warfarin Subjects currently receive thiazolidinediones , unless treatment discontinue 8 week screen visit Significant diabetic complication ( retinopathy , nephropathy , symptomatic neuropathy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Diabetes</keyword>
</DOC>